Page last updated: 2024-10-16

carnitine and Purpura, Thrombocytopenic, Idiopathic

carnitine has been researched along with Purpura, Thrombocytopenic, Idiopathic in 1 studies

Purpura, Thrombocytopenic, Idiopathic: Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.

Research Excerpts

ExcerptRelevanceReference
" Previous reports indicate that ELT is mainly eliminated in the liver, although its pharmacokinetic profile has not yet been clarified in detail."1.37Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent. ( Horikawa, M; Ishiwata, N; Kato, Y; Matsubara, K; Nakamichi, N; Silver, DL; Sugiura, T; Takeuchi, K; Umeda, S, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takeuchi, K1
Sugiura, T1
Umeda, S1
Matsubara, K1
Horikawa, M1
Nakamichi, N1
Silver, DL1
Ishiwata, N1
Kato, Y1

Other Studies

1 other study available for carnitine and Purpura, Thrombocytopenic, Idiopathic

ArticleYear
Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:6

    Topics: Animals; Benzoates; Blood Platelets; Cell Line; Dose-Response Relationship, Drug; Hepatocytes; Human

2011